{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T01:07:26Z","timestamp":1648602446406},"reference-count":31,"publisher":"Elsevier BV","issue":"1-4","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.prostaglandins.2005.04.002","type":"journal-article","created":{"date-parts":[[2005,5,27]],"date-time":"2005-05-27T15:37:19Z","timestamp":1117208239000},"page":"96-106","source":"Crossref","is-referenced-by-count":1,"title":["Urinary 8-isoprostaglandin F2\u03b1 level in Beh\u00e7et's disease"],"prefix":"10.1016","volume":"78","author":[{"given":"Nalan \u00c7i\u00e7ek","family":"\u00d6zd\u00f6l","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A\u015fk\u0131n","family":"Ate\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olcay Tiryaki","family":"Ayd\u0131ntu\u011f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Melli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2005.04.002_bib1","first-page":"701","article-title":"Clinical studies on Beh\u00e7et's syndrome","volume":"9","author":"Oshima","year":"1962","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib2","first-page":"1152","article-title":"\u00dcber rezidivierende apht\u00f6se, durc ein Virus verursachte Geschw\u00fcre am Mund, am Auge und an den Genitalien","volume":"105","author":"Beh\u00e7et","year":"1937","journal-title":"Dermatol Wochenschr"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib3","first-page":"247","article-title":"Auto-oxidative damage in Beh\u00e7et's disease-endothelial cell damage following the elevated oxygen radicals generated stimulated neutrophils","volume":"49","author":"Niwa","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib4","first-page":"227","article-title":"Enhanced superoxide scavenging activity of peripheral blood leucocytes in Beh\u00e7et's disease-effects of colchicines","volume":"9","author":"Pronai","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib5","doi-asserted-by":"crossref","unstructured":"Tutkak H, Yurtaslan\u0131 Z, Tokg\u00f6z G, Ayd\u0131ntu\u011f AO, D\u00fczg\u00fcn N, G\u00fcrler A. Superoxide dismutase activity of plasma, erythrocyte and lymphocytes (T,B) in patients with Beh\u00e7et's disease. In: Godeau P, Wechsler B, editors. Beh\u00e7et's disease. Elsevier Science Publishers B.V.","DOI":"10.1016\/S0248-8663(05)82437-3"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib6","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1073\/pnas.87.23.9383","article-title":"A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism","volume":"87","author":"Morrow","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib7","doi-asserted-by":"crossref","first-page":"23185","DOI":"10.1074\/jbc.271.38.23185","article-title":"Nonenzymatic free radical, catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo","volume":"271","author":"Morrow","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib8","doi-asserted-by":"crossref","first-page":"17273","DOI":"10.1074\/jbc.270.29.17273","article-title":"Isoleukotrienes are biologically active free radical products of lipid peroxidation","volume":"270","author":"Harrison","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0014-5793(95)00649-T","article-title":"Plasma 8-epi-PG F2\u03b1 levels are elevated in individuals with non-insulin dependent diabetes mellitus","volume":"368","author":"Gopaul","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.99.2.224","article-title":"In vivo formation of 8-iso-prostaglandin F F2\u03b1 and platelet activation in diabetes mellitus. Effects of improved metabolic control and Vitamin E supplementation","volume":"99","author":"Davi","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib11","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1161\/01.CIR.98.25.2822","article-title":"Increased formation of distinct F2-isoprostanes in hypercholesterolemia","volume":"98","author":"Reilly","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib12","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1161\/01.CIR.96.10.3314","article-title":"Increased formation of the isoprostanes IPF2\u03b1 -I and 8-iso-PGF2\u03b1 in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans","volume":"96","author":"Reilly","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9343(00)00547-7","article-title":"Oxidative injury in the central nervous system-focus on Alzheimer's disease","volume":"109","author":"Pratico","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib14","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/art.1780390711","article-title":"Evidence of free radical mediated injury (isoprostane overproduction) in scleroderma","volume":"39","author":"Stein","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib15","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood.V90.10.3931","article-title":"Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies","volume":"90","author":"Iuliano","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib16","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/ard.60.6.627","article-title":"Raised level of F2-isoprostanes and prostaglandin F2\u03b1 in different rheumatic diseases","volume":"60","author":"Basu","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib17","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et's disease","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib18","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of SLE","volume":"25","author":"Tan","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib19","first-page":"467","article-title":"Enzyme immunoassay of eicosanoids using AchE as label: an alternative to RIA","volume":"57","author":"Pradelles","year":"1985","journal-title":"Anal Biochem"},{"issue":"2","key":"10.1016\/j.prostaglandins.2005.04.002_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00915994","article-title":"Oxygen radicals production by neutrophils from patients with bacterial infection and rheumatoid arthritis. Measurement of hydrogen peroxide may most accurately represent enhancement of oxygen radical production during infection","volume":"10","author":"Ozaki","year":"1986","journal-title":"Inflammation"},{"issue":"2","key":"10.1016\/j.prostaglandins.2005.04.002_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0009-8981(01)00569-1","article-title":"Chemiluminescence in inflammatory bowel disease: a parameter of inflammatory activity","volume":"310","author":"Oldenburg","year":"2001","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.1016\/j.prostaglandins.2005.04.002_bib22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0891-5849(03)00280-6","article-title":"Reactive oxygen species in pulmonary inflammation by ambient particulates","volume":"35","author":"Tao","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib23","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/0006-2952(94)90389-1","article-title":"Effect of oxygen tension on the generation of F2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomes","volume":"47","author":"Longmire","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib24","series-title":"Proceedings of the 41st ASMS Conference on Mass Spectrometry","article-title":"A comparison of gas chromatography\u2013mass spectrometry assays for in vivo lipid peroxidation","author":"Matthews","year":"1993"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib25","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1172\/JCI117107","article-title":"Formation of non-cyclooxygenase derived prostanoids (F2-isoprostanes) in human plasma and isolated low density lipoproteins exposed to metal ion-dependent and -independent oxidative stess","volume":"93","author":"Lynch","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib26","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJM199505043321804","article-title":"Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers","volume":"332","author":"Morrow","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.CIR.94.1.19","article-title":"Modulation of oxidant stress in vivo in chronic cigarette smokers","volume":"94","author":"Reilly","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1024\/0301-1526.29.2.103","article-title":"Isoprostanes quickly normalize after quitting cigarette smoking in healthy adults","volume":"29","author":"Oguogho","year":"2000","journal-title":"Vasa"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1572-0241.2002.05427.x","article-title":"Increased urinary F2-isoprostanes in patients with Crohn's disease","volume":"97","author":"Cracowski","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib30","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1212\/WNL.52.3.562","article-title":"Increased CSF F2-isoprostane concentration in probable AD","volume":"52","author":"Montine","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.prostaglandins.2005.04.002_bib31","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1096\/fasebj.12.15.1777","article-title":"Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo","volume":"12","author":"Pratico","year":"1998","journal-title":"FASEB J"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882305000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882305000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T12:41:28Z","timestamp":1586263288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882305000419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":31,"journal-issue":{"issue":"1-4","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S1098882305000419"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2005.04.002","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}